Tumor and bone marrow uptakes on [18F]fluorodeoxyglucose positron emission tomography/computed tomography predict prognosis in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapy.

Chang, Chin-Chuan

Tumor and bone marrow uptakes on [18F]fluorodeoxyglucose positron emission tomography/computed tomography predict prognosis in patients with diffuse large B-cell lymphoma receiving rituximab-containing chemotherapy. [electronic resource] - Medicine Nov 2017 - e8655 p. digital

Publication Type: Journal Article

1536-5964

10.1097/MD.0000000000008655 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Immunological--therapeutic use
Female
Fluorodeoxyglucose F18
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Lymphoma, Large B-Cell, Diffuse--diagnostic imaging
Male
Middle Aged
Multivariate Analysis
Positron Emission Tomography Computed Tomography
Prognosis
Proportional Hazards Models
Radiopharmaceuticals
Retrospective Studies
Rituximab--therapeutic use
Whole Body Imaging
Young Adult